The trefoil peptide family

Annual Review of Physiology

Volumn 58, Issue , 1996, Pages 253-273

  Sands, B E ^a   Podolsky, D K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

ITF; mucin glycoprotein; pS2; spasmolytic polypeptide; wound healing

Indexed keywords

MUCIN; TREFOIL PEPTIDE;

DIGESTIVE SYSTEM ULCER; DISULFIDE BOND; GASTROINTESTINAL MUCOSA; MUCOUS CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STOMACH ACID SECRETION; STOMACH MOTILITY; ULCER HEALING;

EID: 0029929320     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.ph.58.030196.001345     Document Type: Review

References (87)

1. Babyatsky MW, Thim L, Podolsky DK. 1994. Trefoil peptides protect against ethanol and indomethacin induced gastric injury in rats. Gastroenterology 106: A43 (Abstr.)
2. Berry M, Nunez A-M, Chambon P. 1989. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA 86:1218-22
3. Bork P. 1993. A trefoil domain in the major rabbit zona pellucida protein. Protein Sci. 2:669-70
4. Brown AMC, Jeltsch J-M, Roberts M, Chambon P. 1984. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sci. USA 81:6344-48
5. 1H NMR-based determination of the secondary structure of procine pancreatic spasmolytic polypeptide: one of a new family of "Trefoil" motif containing cell growth factors. Biochemistry 31:1998-2004
6. Carr MD, Bauer CJ, Gradwell MJ, Feeney J. 1994. Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. Proc. Natl. Acad. Sci. USA 91:2206-10
7. Chinery R, Bates PA, De A, Freemont PS. 1995. Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers. FEBS Lett. 357:50-54
8. Chinery R, Poulsom R, Elia G, Hanby AM, Wright NA. 1993. Expression and purification of a trefoil peptide motif in a β-galactosidase fusion protein and its use to search for trefoil-binding sites. Eur. J. Biochem. 212:557-63
9. Chinery R, Poulsom R, Robert LA, Jeffery RE, Longcroft JM, et al. 1992. Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by hybridization in situ. Biochem. J. 285:5-8
10. Chinery R, Poulsom R, Wright NA. 1995. mITF, a mouse trefoil peptide homologous with rat intestinal trefoil factor, is located on murine chromosome 15. Gastroenterology 108(4):A456 (Abstr.)
11. Ciacci C, Lind SE, Podolsky DK. 1993. Transforming growth factor β regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 105:93-101
12. Cook GA, Skultety KJ, Yeomans ND, Giraud AS. 1994. Increased trefoil peptide expression in a rat model of intestinal repair. Gastroenterology 106:A195 (Abstr.)
13. Cook GA, Yeomans ND, Giraud AS. 1995. Trefoil peptide expression falls following gastric mucosal injury but is induced in a TGFα-dependent manner late in repair. Gastroenterology 108: A75 (Abstr.)
14. Cox HM, Chinery R, Wright NA. 1993. An epithelial ion transport role of intestinal trefoil factor but not for pancreatic spasmolytic polypeptide. Regul. Pept. 47:90
15. Davidson NE, Bronzert DA, Chambon P, Gelmann EP, Lippman ME. 1986. Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products. Cancer Res. 46:1904-8
16. De A, Brown DG, Gorman MA, Carr M, Sanderson MR, Freemont PS. 1994. Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors. Proc. Natl. Acad. Sci. USA 91:1084-88
17. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. 1994. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. J. Clin. Invest. 94:376-33
18. Dignass A, Podolsky DK. 1993. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor β. Gastroenterology 105:1323-32
19. Foekens JA, Rio M-C, Seguin P, van Putten WLJ, Fauque J, et al. 1990. Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res. 50:3832-37
20. Frandsen EK, Jørgensen KH, Thim L. 1986. Receptor binding of pancreatic spasmolytic polypeptide (PSP) in rat intestinal mucosal cell membranes inhibits the adenylate cyclase activity. Regul. Pept. 16:291-97
21. Gajhede M, Petersen TN, Henriksen A, Petersen JFW, Dauter Z, et al. 1993. Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides. Structure 1(4):253-62
22. Gmach M, Berger H, Thalhammer J, Kreil G. 1990. Dermal glands of Xenopus laevis contain a polypeptide with a highly repetitive amino acid sequence. FEBS Lett. 260:145-48
23. Hanby AM, Jankowski J, Poulsom R, Singh S, Elia G, Wright NA. 1992. Expression of pS2 and hSP in Barrett's mucosa and oesophageal carcinoma. Gut 33:532 (Abstr.)
24. Hanby AM, Poulsom R, Elia G, Singh S, Longcroft JM, Wright MA. 1993. The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in "gastric metaplasia" of the proximal duodenum: implications for the nature of "gastric metaplasia." J. Pathol. 169:355-60
25. Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA. 1993. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 105:1110-16
26. Hanby AM, Poulsom R, Singh S, Jankowski J, Hopwood D, et al. 1993. Hyperplastic polyps: a cell lineage which both synthesizes and secretes trefoil-peptides and has phenotypic similarity with the ulcer-associated cell lineage. Am. J. Pathol. 142(3):663-68
27. Hauser F, Gertzen E-M, Hoffmann W. 1990. Expression of spasmolysin (FIM-A.1): an integumentary mucin from Xenopus laevis. Exp. Cell Res. 189:157-62
28. Hauser F, Hoffmann W. 1991. xPI and xP4. P-domain peptides expressed in Xenopus laevis stomach mucosa. J. Biol. Chem. 266(31):21306-9
29. Hauser F, Hoffmann W. 1992. P-domains as shuffled cysteine-rich modules in integumentary mucin C.1 (FIM-C.1) from Xenopus laevis. Polydispersity and genetic polymorphism. J. Biol. Chem. 267(34):24620-24
30. Hauser F, Poulsom R, Chinery R, Rogers LA, Hanby AM, et al. 1993. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc. Natl. Acad. Sci. USA 90:6961-65
31. Hauser F, Roeben C, Hoffmann W. 1992. xP2, a new member of the P-domain peptide family of potential growth factors, is synthesized in Xenopus laevis skin. J. Biol. Chem. 267(20):14451-55
32. Henry JA, Bennett MK, Piggott NH, Levett DL, May FEB, Westley BR. 1991. Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br. J. Cancer 64:677-82
33. Hoffmann W. 1988. A new repetitive protein from Xenopus laevis skin highly homologous to pancreatic spasmolytic polypeptide. J. Biol. Chem. 263(16): 7686-90
34. Hoffmann W, Hauser F. 1993. The P-domain or trefoil motif: a role in renewal and pathology of mucous eithelia? Trends Biochem. Sci. 18:239-43
35. Hoosein NM, Thim L, Jørgensen KH, Brattain MG. 1989. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Lett. 247(2):303-6
36. Jakowlew SB, Breathnach R, Jeltsch J-M, Masiakowski P, Chambon P. 1984. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res. 12(6): 2861-77
37. Jeffrey GP, Oates PS, Wang TC, Babyatsky MW, Brand SJ. 1994. Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucous cells. Gastroenterology 106:336-45
38. Jeltsch J-M, Roberts M, Schatz C, Garnier JM, Brown AMC, Chambon P. 1987. Structure of the human oestrogen-responsive gene pS2. Nucleic Acids Res. 15(4):1401-14
39. Jørgensen KD, Diamant B, Jørgensen KH, Thim L. 1982. Pancreatic spasmolytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul. Pept. 3:231-43
40. Jørgensen KH, Thim L, Jacobsen HE. 1982. Pancreatic spasmolytic polypeptide (PSP): 1. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul. Pept. 3:207-19
41. Kida N, Yoshimura T, Mori K, Havasm K. 1989. Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7). Cancer Res. 49:3494-98
42. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK. 1995. Trefoil peptides protect intestinal epithelial monolayer/barrier function: co-operative interaction with mucin glycoprotein. Gastroenterology. In press
43. Koerner FC, Goldberg DE, Edgerton SM, Schwartz LH. 1992. pS2 protein and steroid hormone receptors in invasive breast carcinomas. Int. J. Cancer 52:183-38
44. Lefebvre O, Wolf C, Kédinger M, Chenard M-P, Tomasetto C, et al. 1993. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of extression. J. Cell Biol. 122 (1):191-98
45. Luqmani YA, Ryall G, Shousha S, Coombes RC. 1992. An immunohistochemical survey of pS2 expression in human epithelial cancers. Int. J. Cancer 50:302-4
46. Mashimo H, Podolsky DK, Fishman MC. 1995. Structure and expression of murine intestinal trefoil factor: high evolutionary conservation and post-natal expression. Biochem. Biophys. Res. Commun. 210:31-37
47. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P. 1982. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10(24):7893-903
48. May FEB, Westley BR. 1986. Cloning of estrogen-regulated messenger RNA sequences from human breast cancer cells. Cancer Res. 46:6034-40
49. May FEB, Westley BR. 1988. Identification and characterization of estrogen-regulated RNAs in human breast cells. J. Biol. Chem. 263:12901-8
50. Ménard D, Pothier P. 1991. Radiographic localization of epidermal growth factor receptors in human fetal gut. Gastroenterology 101:640-64
51. Mori K, Fujii R, Kida N, Ohta M, Hayaski K. 1988. Identification of a polypeptide secreted by human breast cancer cells (MCF-7) as the human estrogen-responsive gene (pS2) product. Biochem. Biophys. Res. Commun. 155: 366-72
52. Nunez A-M, Berry M, Imler J-L, Chambon P. 1989. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J. 8(3): 823-29
53. Nunez A-M, Jakowlev S, Briand J-P, Gaire M, Krust A, et al. 1987. Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7. Endocrinology 121(5):1759-65
54. Otto B, Wright N. 1994. Trefoil peptides: coming up clover. Curr. Biol. 4(9):835-38
55. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, et al. 1995. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108:108-16
56. Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, et al. 1993. Identification of human intestinal trefoil factor: goblet cell-specific expression of a peptide targeted for apical secretion. J. Biol. Chem. 268(9):6694-702
57. Prud'Homme J-F, Fridlansky F, Le Cunff M, Atger M, Mercier-Bodard C, et al. 1985. Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA 4:11-21
58. Rio M-C, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, et al. 1988. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 241:705-8
59. Rio M-C, Bellocq JP, Gairard B, Koehl C, Renaud R, Chambon P. 1988. Specific expression of human pS2 gene in breast cancer. Biochimie 70:961-68
60. Rio M-C, Bellocq JP, Gairard B, Rasmussen UB, Krust A, et al. 1987. Specific expression of th pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc. Natl. Acad. Sci. USA 84:9243-47
61. Rio M-C, Chambon P. 1990. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Cancer Cells 2(8-9):269-74
62. Rio M-C, Chenard M-P, Wolf C, Marcellin L, Tomasetto C, et al. 1991. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 100:375-79
63. Sands BE, Ogata H, Lynch-Devaney K, deBeaumont M, Ezzell RM, Podolsky DK. 1995. Molecular cloning of the rat intestinal trefoil factor gene: characterization of an intestinal goblet cell-associated promoter. J. Biol. Chem. 270 (16):9353-61
64. Schwartz LH, Koerner FC, Edgerton SM, Sawicka JM, Rio M-C, et al. 1991. pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res. 51:624-28
65. Seitz G, Thelsinger B, Tomasetto G, Rio M-C, Chambon P, et al. 1991. Breast cancer-associated protein pS2 expression in tumors of the binary tract. Am. J. Gastroenterol. 86(10):1491-94
66. Skilton RA, Luqmani YA, McLelland RA, Coombes RC. 1989. Characterization of a messenger RNA selectively expressed in human breast cancer. Br. J. Cancer 60:168-75
67. Stettler Ch, Schmassmann A, Poulsom R, Hirschi C, Flogerzi B, et al. 1995. Effect of hepatocyte growth factor on expression of trefoil peptides in injured gastric mucosa. Gastroenterology 108: A226 (Abstr.)
68. Suemori S, Lynch-Devaney K, Podolsky DK. 1991. Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc. Natl. Acad. Sci. USA 88:11017-21
69. Takahasi H, Kida N, Fujii R, Tanaka K, Ohta M, et al. 1990. Expression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinoma. FEBS Lett. 261(2): 283-86
70. Taupin DR, Cook GA, Yeomans ND, Giraud AS. 1994. Increased trefoil peptide expression occurs late in the healing phase in a model of gastric ulceration in the rat. Gastroenterology 106:A195 (Abstr.)
71. Taupin DR, Ooi K, Shulkes A, Giraud AS. 1994. Identification of human intestinal trefoil factor in the colonic adenoma-carcinoma sequence. Gastroenterology 106:A635 (Abstr.)
72. Theisinger B, Welter C, Grzeschik K-H, Blin N. 1992. Assignment of the gene for human spasmolytic protein (hSP/S ML1) to chromosome 21. Hum. Genet. 89:681-82
73. Thim L. 1988. A surprising sequence homology. Biochem. J. 253:309
74. Thim L. 1989. A new family of growth factor-like peptides: "trefoil" disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett. 250(1):85-90
75. Thim L. 1994. Trefoil peptides: a new family of gastrointestinal molecules. Digestion 55:353-60
76. Thim L, Jørgensen KH, Jørgensen KD. 1982. Pancreatic spasmolytic polypeptide (PSP): II. radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice. Regul. Pept. 3:221-30
77. Thim L, Norris K, Norris F, Nielsen PF, Bjorn SE, et al. 1993. Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast. FEBS Lett 318(3):345-52
78. Thim L, Thomsen J, Christensen M, Jørgensen KH. 1985. The amino acid sequence of pancreatic spasmolytic polypeptide. Biochim. Biophys. Acta 827:410-18
79. Thim L, Wöldike HF, Nielsen PF, Christensen M, Lynch-Devaney K, Podolsky DK. 1995. Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry 34(14):4757-64
80. Tomasetto C, Rio M-C, Gautier C, Wolf C, Hareuveni M, et al. 1990. hSP, the domain-duplicated homolog of pS2, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J. 9(2):407-14
81. Tomasetto C, Rockel N, Mattei MG, Fujita R, Rio M-C. 1992. The gene encoding the human spasmolytic protein (SML1/hSP) is in 21q22.3, physically linked to the homologous breast cancer marker gene BCEI/pS2. Genomics 13: 1328-30
82. Tomasetto C, Wolf C, Rio M-C, Mehtali M, LeMeur M, et al. 1989. Breast cancer protein pS2 synthesis in mammary gland of transgenic mice and secretion into milk. Mol Endocrinol. 3(10):1579-84
83. Wright NA. 1993. Trefoil peptides and the gut. Gut 34:577-79
84. Wright NA, Pike C, Elia G. 1990. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 343:82-85
85. Wright NA, Poulsom R, Stamp G, Van Norden S, Sarraf C, et al. 1992. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Scand. J. Gastroenterol. 27(Suppl. 193):76-82
86. Wright NA, Poulsom R, Stamp GWH, Hall PA, Jeffery RE, et al. 1990. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J. Pathol. 162:279-84
87. Wu GD, Beer DG, Moore JH, Orringer MB, Appelman HD, Traber PG. 1993. Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma. Gastroenterology 105:837-44